Gender-dependent associations of uric acid levels with a polymorphism in SLC2A9 in Han Chinese patients

Scandinavian Journal of Rheumatology

Volumn 41, Issue 2, 2012, Pages 161-163

  Hu, M ^a   Tomlinson, B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

CARDIOVASCULAR RISK; CHINESE; GENE; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; URIC ACID BLOOD LEVEL;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GOUT; HUMANS; HYPERURICEMIA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; URIC ACID;

EID: 84858396943     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.637952     Document Type: Letter

References (10)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-21.
2. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:170-80.
3. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372:1953-61.
4. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008;40:430-6.
5. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
7. Hu M, Lui SS, Mak VW, Chu TT, Lee VW, Poon EW, et al. Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. Pharmacogenet Genomics 2010;20:634-7.
8. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-62.
9. Cummings N, Dyer TD, Kotea N, Kowlessur S, Chitson P, Zimmet P, et al. Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate. Eur J Hum Genet 2010; 18:1243-7.
10. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim Biophys Acta 2004;1681:53-8.